Published in J Immunol on April 15, 2002
Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role. Blood (2012) 1.30
Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br J Pharmacol (2005) 1.20
Inhibition of monocytic interleukin-12 production by Candida albicans via selective activation of ERK mitogen-activated protein kinase. Infect Immun (2004) 1.01
Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infection. Clin Diagn Lab Immunol (2004) 0.84
Pathological role of large intestinal IL-12p40 for the induction of Th2-type allergic diarrhea. Am J Pathol (2004) 0.82
Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin Immunopathol (2006) 0.78
Histamine down-regulates IL-27 production in antigen-presenting cells. J Leukoc Biol (2012) 3.12
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. N Engl J Med (2015) 2.44
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol (2012) 2.28
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy. J Clin Oncol (2013) 2.22
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.87
Human inflammatory dendritic epidermal cells express a functional histamine H4 receptor. J Invest Dermatol (2008) 1.73
MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer (2010) 1.62
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. Arch Dermatol (2007) 1.59
Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J Invest Dermatol (2008) 1.58
Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Am J Surg Pathol (2007) 1.58
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol (2010) 1.55
Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretion. Exp Dermatol (2011) 1.53
Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single center. Cancer (2010) 1.42
The hand-foot-syndrome associated with medical tumor therapy - classification and management. J Dtsch Dermatol Ges (2010) 1.40
The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol (2004) 1.35
Urticaria and infections. Allergy Asthma Clin Immunol (2009) 1.28
Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol (2008) 1.28
Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol (2005) 1.27
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol (2007) 1.22
Chronic urticaria and infections. Curr Opin Allergy Clin Immunol (2004) 1.13
Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature. Dermatology (2009) 1.12
High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet (2013) 1.11
Investigation of contact allergy to dental metals in 206 patients. Contact Dermatitis (2009) 1.10
Atypical cutaneous herpes virus infection associated with fludarabine chemotherapy of lymphoma. Eur J Dermatol (2007) 1.07
Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol (2005) 1.07
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol (2006) 1.06
IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol (2012) 1.04
Dynamic changes in nevi of a patient with melanoma treated with vemurafenib: importance of sequential dermoscopy. Arch Dermatol (2012) 1.03
The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol (2008) 1.03
The histamine H4 receptor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol (2009) 1.01
IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitis. J Invest Dermatol (2006) 1.00
Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma. Int J Cancer (2011) 0.99
Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol (2008) 0.99
Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis. J Allergy Clin Immunol (2011) 0.98
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Linking allergy to autoimmune disease. Trends Immunol (2009) 0.97
Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. J Allergy Clin Immunol (2007) 0.96
Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol (2002) 0.95
Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun (2011) 0.94
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha. Int J Cancer (2007) 0.93
Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology (2005) 0.93
Modulation of keratinocyte-derived MMP-9 by IL-13: a possible role for the pathogenesis of epidermal inflammation. J Invest Dermatol (2007) 0.93
Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy? J Allergy Clin Immunol (2009) 0.93
Structured education program improves the coping with atopic dermatitis in children and their parents-a multicenter, randomized controlled trial. J Psychosom Res (2009) 0.91
Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol (2006) 0.91
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis. J Allergy Clin Immunol (2010) 0.91
Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology (2004) 0.91
Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. Arthritis Rheum (2008) 0.90
microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells. Exp Dermatol (2012) 0.90
Cooking birch pollen-related food: divergent consequences for IgE- and T cell-mediated reactivity in vitro and in vivo. J Allergy Clin Immunol (2006) 0.90
Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. Am J Clin Dermatol (2005) 0.89
Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. J Allergy Clin Immunol (2002) 0.89
Evidence for a regulatory loop between IFN-γ and IL-33 in skin inflammation. Exp Dermatol (2013) 0.89
Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol (2006) 0.89
Rapid identification and differentiation of fungal DNA in dermatological specimens by LightCycler PCR. J Med Microbiol (2004) 0.89
Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Exp Dermatol (2008) 0.88
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol (2012) 0.88
Staphylococcus aureus-derived enterotoxins enhance house dust mite-induced patch test reactions in atopic dermatitis. Exp Dermatol (2007) 0.88
RAC1 in keratinocytes regulates crosstalk to immune cells by Arp2/3-dependent control of STAT1. J Cell Sci (2012) 0.88
Delayed-type hypersensitivity to protamine as a complication of insulin therapy. Contact Dermatitis (2005) 0.88
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. J Am Acad Dermatol (2005) 0.88
Role of macrophages in the pathogenesis of atopic dermatitis. Mediators Inflamm (2013) 0.88
The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration. J Invest Dermatol (2011) 0.87
A protective role of complement component 3 in T cell-mediated skin inflammation. Exp Dermatol (2011) 0.87
Pharmacological characterization of the new histamine H4 receptor agonist VUF 8430. Br J Pharmacol (2009) 0.87
Skin testing with food allergens. Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), the Physicians' Association of German Allergologists (ADA) and the Society of Pediatric Allergology (GPA) together with the Swiss Society of Allergology. J Dtsch Dermatol Ges (2008) 0.87
Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol (2002) 0.87
IL-27 Regulates IL-18 binding protein in skin resident cells. PLoS One (2012) 0.87
Innate immunity, allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol (2010) 0.86
[Atopic dermatitis: S2 guidelines]. J Dtsch Dermatol Ges (2009) 0.86
Human dendritic cells express the IL-18R and are chemoattracted to IL-18. J Immunol (2003) 0.86
Primary human keratinocytes efficiently induce IL-1-dependent IL-17 in CCR6+ T cells. Exp Dermatol (2010) 0.86
Allergy prevention. Dtsch Arztebl Int (2009) 0.85
Staphylococcal α-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis. Int Arch Allergy Immunol (2011) 0.85
Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunol (2005) 0.85
Eosinophil granulocytes: functional differences of a new isolation kit compared to the isolation with anti-CD16-conjugated MicroBeads. Exp Dermatol (2009) 0.85
Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2. Immunology (2003) 0.84
Human memory Th17 cells express a functional histamine H4 receptor. Am J Pathol (2011) 0.84